Brief: Abbisko Cayman Says IND Approval By NMPA Obtained For Absk112
27/10/2023 02:33
Oct 27 (Reuters) - Abbisko Cayman Ltd 2256.HK :
* IND APPROVAL BY NMPA OBTAINED FOR ABSK112
Further company coverage: 2256.HK
Recent news on Abbisko Cayman
See all newsHK-listed Abbisko climbs most in 12 weeks on Eli Lilly tie-up
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly (updated)
Brief: Abbisko Therapeutics Deepens R+D- Collaboration With Lilly
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly
Brief: Abbisko Therapeutics Enters Strategic Research Collaboration And License Agreement With Eli Lilly